Navigation Links
Market for Select Cardiovascular Drugs in the GCC Region-2012-16
Date:9/24/2013

DUBLIN, September 24, 2013 /PRNewswire/ --

Research and Markets
( http://www.researchandmarkets.com/research/xvj2zn/market_for_select) has announced the addition of the "Market for Select Cardiovascular Drugs in the GCC Region-2012-16" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)


The $7.6 bn Pharmaceutical industry in the GCC region is poised for major growth in the coming years. Increase in the international crude oil prices and exports of crude and petro products have transformed the GCC economy. The local governments are increasingly focusing on improving the health and living standards of the population. Contraints in local manufacturing capacity and thriving counterfeit drugs market pose a major challenge but improved regulatory mechanism, increase in private sector participation coupled with rising private and public sector outlay and spend on healthcare presents a promising future for the industry.

This report focuses on the market for select cardiovascular drugs in the GCC region. Various market drivers in terms of changing lifestyle and rising disease incidence among the population has led to higher consumption of cardiovascular drugs in the region. Sensing the latent market opportunity, global pharma majors such as Novartis, Abbott, AstraZeneca have set up operations in the GCC region through local joint venture and distribution.

In addition to market forecast to 2016, the report also provides interesting insights into key molecules used, top brands, drug prices, procurement process among government and retail institutions. The report will serve as an effective guide for the drug companies, distributors, hospitals and other stakeholders who wish to enter the GCC healthcare market. The report also has profiles of companies and distributors in the GCC region."

Key Topics Covered:

1. Methodology

2. Report Coverage

3. Glossary of terms

4. Executive summary

5. Healthcare sector in GCC

6. Pharmaceutical market in GCC

7. Cardiovascular market for select drugs in GCC

8. Profiles of key domestic pharmaceutical manufacturers

9. Annexure - Drugs price details by country - 2012

List of Exhibits

Companies Mentioned

- AstraZeneca
- Global Pharma
- Jamjoom Pharma
- Julphar - Gulf Pharmaceutical Industries
- Kuwait Saudi Pharmaceutical Industries
- Merck & Co., Inc
- National Pharmaceutical Industries Co
- Neo Pharma
- Novartis International AG
- Oman Pharmaceutical Products Co. L.L.C
- Pfizer, Inc
- Sanofi S.A.
- Saudi Pharmaceutical Industries & Medical Appliances Corporation
- Tabuk Pharmaceuticals Manufacturing Company

For more information visit http://www.researchandmarkets.com/research/xvj2zn/market_for_select

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +353-1-481-1716


Sector: Healthcare and Medical Devices


'/>"/>
SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. The US Ear, Nose And Throat And Bronchoscopy Device Markets Will Reach A Combined Value Exceeding $715 Million In 2021
2. Market for Local Anaesthesia in the GCC Region 2012-17
3. FDAs Plan & Congressional Take on Mobile Medical Apps Market
4. New Pharmaceutical Product Launch Spend: Developing Competitive Launch and Pre-launch Budgets to Ensure a Successful Market Entry
5. Rafarma Pharmaceuticals, Inc. (RAFA) announces plans for PCAOB-Registrant Audit and Streamlining of Corporate Structure to Upgrade Market Listing.
6. Clinical Trial Results, Litigation Outcomes and Marketing Authorizations - Research Report on Pfizer, GlaxoSmithKline, Sanofi, AstraZeneca, and Neurocrine
7. iConcept Launches GIS-Based CRM Tools to Reach Non-Captive Market
8. Cloud-Based Online Registration Platform Licensale.com Revolutionizes Medical Device Market
9. The US Market for Electronic Medical Records Will Decline Due to Market Saturation
10. Montmed to Launch DiaClin General & Diabetic Skin Care Product Line for Canadian Marketplace
11. Obesity Therapeutics to 2019 - Safety Concerns Hinder Drug Performance Despite Large Market Opportunity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... , March 27, 2017 LightIntegra Technology Inc. ... William "Bill" Dubiel as President and Chief Executive Officer ... to the Board of Directors of LightIntegra. Paul ... Chairman of LightIntegra. "This is the ... and Chief Executive Officer. We,ve selected a very strong ...
(Date:3/27/2017)... and VANCOUVER, British Columbia, March 27, 2017 /PRNewswire/ ... (the "Company" or "Sophiris"), a clinical late-stage biopharmaceutical ... patients with urological diseases, today reported fourth quarter ... corporate highlights. Key Corporate Highlights: ... Development for Localized Prostate Cancer. During 2016, the ...
(Date:3/27/2017)... , March 27, 2017   Pulmatrix, Inc . (NASDAQ: ... to address serious pulmonary diseases, today announced that it has ... cystic fibrosis and asthma to its Scientific Advisory Board ... Richard B. Moss , MD, former chief of ... the Cystic Fibrosis Center at Stanford University, and ...
Breaking Medicine Technology:
(Date:3/28/2017)... ... 28, 2017 , ... Via Oncology, the leading provider of ... free, public-facing tool for analyzing the costs of various drug regimens in cancer ... to patients, providers, insurers and pharmaceutical companies about the estimated costs of treatment ...
(Date:3/28/2017)... ... March 28, 2017 , ... Alert Sentry Group LLC., a leader in ... Response Systems), the iSAFE and the iSAFE Plus. These iSAFE products are the most ... kind, the iSAFE and iSAFE Plus offer direct GPS Location and two-way calling with ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... the University of Pittsburgh Medical Center (UPMC) will acquire QuikClot® Bleeding Control Kits® ... The program, developed in association with efforts by the American College of Surgeons, ...
(Date:3/28/2017)... ... 2017 , ... WHO: , Dr. Paul Thomas; Dr. Brian Hooker; Dr. Judy ... PhD scientists will speak to the press on behalf of over 200 doctors, scientists, ... vaccine safety commission. , WHERE: , Zenger Room, National Press Club, 529 14th ...
(Date:3/28/2017)... ... 28, 2017 , ... Usually, the impending arrival of warmer weather means the ... about a double chin, this means more anxiety than elation. The cosmetic dermatology experts ... people, a double chin is undesirable,” Dr. Goldman said, “but it seems doubly so ...
Breaking Medicine News(10 mins):